RADX

Radiopharm Theranostics LimitedNASDAQHealthcare

$4.40+1.85%ClosedMarket Cap: $5.7M

As of 2026-04-06

Valuation

P/E (TTM)

—

PEG

—

P/B

0.99

P/S

2.27

EV/EBITDA

0.55

DCF Value

$-44.35

FCF Yield

-445.0%

Div Yield

0.0%

Margins & Returns

Gross Margin

1.1%

Operating Margin

-1050.6%

Net Margin

-1055.3%

ROE

-105.2%

ROA

-44.3%

ROIC

-53.4%

Income Statement

Period	Revenue	Gross Margin	Operating Income	Net Income	EPS	Dividend
FY 2024	$3.6M	1.1%	$-38.2M	$-38.3M	$-5.28	—
FY 2023	$299.2K	100.0%	$-36.6M	$-47.9M	$-36.00	—
FY 2022	$292.4K	100.0%	$-34.5M	$-34.6M	$-33.00	—
FY 2021	$8.8K	100.0%	$-19.9M	$-30.3M	$-29.76	—